Last $26.32 USD
Change Today +0.94 / 3.70%
Volume 1.5M
WMGI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
NASDAQ GM
As of 8:10 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

wright medical group inc (WMGI) Snapshot

Open
$25.47
Previous Close
$25.38
Day High
$26.40
Day Low
$25.39
52 Week High
03/17/14 - $33.74
52 Week Low
02/3/15 - $23.56
Market Cap
1.4B
Average Volume 10 Days
1.2M
EPS TTM
$-3.98
Shares Outstanding
51.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for WRIGHT MEDICAL GROUP INC (WMGI)

wright medical group inc (WMGI) Related Businessweek News

No Related Businessweek News Found

wright medical group inc (WMGI) Details

Wright Medical Group, Inc., a specialty orthopaedic company, provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients’ lifestyles worldwide. The company offers products that are used primarily in foot and ankle repair, upper extremity products, and biologics products. Its extremity hardware products include implants and other devices to replace or reconstruct injured or diseased joints and bones of the foot, ankle, hand, wrist, fingers, toes, elbow, and shoulder. The company also provides biologic products, which are used to support treatment of damaged or diseased bone, and tendons and soft tissues; and other biological solutions for surgeons and their patients, as well as offers a bone graft product incorporating antibiotic delivery. Its biological products focus on supporting biological musculoskeletal repair by utilizing synthetic and human tissue-based materials. The company sells its products through a network of employee sales representatives, independent sales representatives, and stocking distributors. Wright Medical Group, Inc. was founded in 1950 and is headquartered in Memphis, Tennessee.

1,180 Employees
Last Reported Date: 02/26/15
Founded in 1950

wright medical group inc (WMGI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $750.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $340.0K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $500.0K
President of International
Total Annual Compensation: $564.0K
Consultant
Total Annual Compensation: $340.0K
Compensation as of Fiscal Year 2013.

wright medical group inc (WMGI) Key Developments

Wright Medical Group Inc. Announces Unaudited Consolidated Financial Results for the Fourth Quarter and Year Ended December 31, 2014; Provides Earnings Guidance for the Year of 2015

Wright Medical Group Inc. announced unaudited consolidated financial results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported net sales of $83.294 million against $67.824 million a year ago. Operating loss was $26.940 million against $23.240 million a year ago. Loss from continuing operations before income was $106.105 million against $24.749 million a year ago. Net loss from continuing operations was $106.968 million or $2.11 per diluted share against $135.211 million or $2.88 per diluted share a year ago. Net loss was $111.230 million or $2.19 per diluted share against $135.029 million or $2.88 per diluted share a year ago. Adjusted LBITDA was $812,000 against $3.166 million a year ago. Net cash used in operating activities was $29.850 million against $42.322 million a year ago. Capital expenditures was $12.897 million against $15.018 million a year ago. LBITDA was $93,833,000 against $14,818,000 a year ago. Loss before tax was $106,105,000 against $24,749,000 a year ago. Adjusted loss before tax was $13,737,000 against $13,015,000 a year ago. Adjusted net loss was $12,868,000 against $7,879,000 a year ago. For the year, the company reported net sales of $298.027 million against $242.330 million a year ago. Operating loss was $99.806 million against $282.206 million a year ago. Loss from continuing operations before income was $246.830 million against $230.403 million a year ago. Net loss from continuing operations was $240.496 million or $4.83 per diluted share against $280.168 million or $6.19 per diluted share a year ago. Net loss was $259.683 million or $5.22 per diluted share against $273.945 million or $6.05 per diluted share a year ago. Adjusted LBITDA was $24.431 against $5.945 million a year ago. Net cash used in operating activities was $116.002 million against $36.601 million a year ago. Capital expenditures was $48.603 million against $37.530 million a year ago. LBITDA was $200,949,000 against $192,503,000 a year ago. Loss before tax was $246,830,000 against $230,403,000 a year ago. Adjusted loss before tax was $71,181,000 against $42,126,000 a year ago. Adjusted net loss was $71,055,000 against $25,220,000 a year ago. The company anticipates 2015 adjusted EBITDA from continuing operations, as described in the GAAP to non-GAAP reconciliation provided later in this release, of negative $22.0 million to negative $27.0 million. The company anticipates adjusted earnings per share from continuing operations, including stock-based compensation, for full-year 2015 of $1.67 to $1.77 per diluted share, based on approximately 51.1 million shares outstanding. While the amount of the non-cash stock-based compensation charges will vary depending upon a number of factors, the company currently estimates that the after-tax impact of those expenses will be approximately $0.24 per diluted share for the full-year 2015.

Wright Medical Seeks Acquisitions

Wright Medical Group Inc. (NasdaqGS:WMGI) announced its intention to commence an offering, subject to market and other conditions, of $400 million aggregate principal amount of cash convertible senior notes due 2020 to be offered and sold to initial purchasers who would resell the notes to qualified institutional buyers. Wright Medical expects to use a portion of the net proceeds from the offering to pay the cost of the cash convertible note hedge transactions. Wright Medical intends to use the remaining net proceeds from the offering for general corporate purposes, including possible acquisitions and to repay up to approximately $250 million aggregate principal amount of the company's outstanding indebtedness in privately negotiated transactions.

Wright Medical Group, Inc. Announces Preliminary, Unaudited Sales Guidance for the Fourth Quarter and Full Year Ended December 31, 2014

Wright Medical Group Inc. announced preliminary, unaudited sales guidance for the fourth quarter and full year ended December 31, 2014. The Company expects revenue for the fourth quarter of 2014 to be approximately $83.3 million, representing growth compared to the year-ago quarter of 23% as reported and 25% on a constant currency basis. For the full year 2014, the Company expects revenue to be approximately $298.0 million, representing growth of 23% both as reported and on a constant currency basis.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WMGI:US $26.32 USD +0.94

WMGI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cyberonics Inc $72.03 USD +0.84
ICU Medical Inc $89.00 USD +0.50
Orthofix International NV $33.64 USD +0.30
RTI Surgical Inc $5.35 USD +0.04
Tornier NV $25.65 USD +0.82
View Industry Companies
 

Industry Analysis

WMGI

Industry Average

Valuation WMGI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.4x
Price/Book 4.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WRIGHT MEDICAL GROUP INC, please visit www.wmt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.